A dose-escalation study of vorinostat in combination with radiotherapy for patients with non-small cell lung cancer

被引：0
|
作者：
Decker, R. H. [1 ]
Gettinger, S. N. [1 ]
Wilson, L. D. [1 ]
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.tps286
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS286
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Vorinostat in combination with gemcitabine and cisplatinum in patients with advanced non-small cell lung cancer (NSCLC): A Phase I dose-escalation study
    Tredaniel, J.
    Descourt, R.
    Moro-Sibilot, D.
    Misset, J.
    Gachard, E.
    Garcia-Vargas, J.
    Roben, E.
    Zalcman, G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] VORINOSTAT, A HISTONE DEACETYLASE INHIBITOR, IN COMBINATION WITH THORACIC RADIOTHERAPY IN ADVANCED NON-SMALL CELL LUNG CANCER: A DOSE ESCALATION STUDY
    Decker, Roy H.
    Gettinger, Scott N.
    Glazer, Peter M.
    Wilson, Lynn D.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1550 - S1551
  • [3] Vorinostat, a Histone Deacetylase Inhibitor, in Combination with Thoracic Radiotherapy in Advanced Non-small Cell Lung Cancer: A Dose Escalation Study
    Decker, R. H.
    Gettinger, S. N.
    Glazer, P. M.
    Wilson, L. D.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S574 - S575
  • [4] Influence of dose calculation algorithms on isotoxic dose-escalation of non-small cell lung cancer radiotherapy
    Panettieri, Vanessa
    Malik, Zafar I.
    Eswar, Chinnamani V.
    Landau, David B.
    Thornton, John M. C.
    Nahum, Alan E.
    Mayles, W. Philip M.
    Fenwick, John D.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2010, 97 (03) : 418 - 424
  • [5] Phase I dose-escalation study of vorinostat in combination with gemcitabine and cisplatinum in patients with advanced non-small-cell lung cancer (NSCLC)
    Teixeira, L.
    Descourt, R.
    Moro-Sibilot, D.
    Misset, J. L.
    Gachard, E.
    Rizvi, S.
    Roben, E.
    Zalcman, G.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 554 - 554
  • [6] Vorinostat in combination with gemcitabine plus platinum in patients with advanced non-small-cell lung cancer: A phase I, dose-escalation study
    Misset, J.
    Tredaniel, J.
    Descourt, R.
    Morot-Sibilot, D.
    Zalcman, G.
    Gachard, E.
    Garcia-Vargas, J.
    Rizvi, S.
    Reiser, D.
    Roben, L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Phase I dose-escalation study of thoracic radiotherapy in combination with gefitinib in patients with IIIB/IV non-small cell lung cancer (NCT00497250)
    Fan, M.
    Xie, L.
    Xu, X.
    Zhang, G.
    Chen, J.
    Fu, X.
    Zhou, X.
    Li, W.
    Jiang, G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [8] Vorinostat and Concurrent Stereotactic Radiosurgery for Non-Small Cell Lung Cancer Brain Metastases: A Phase 1 Dose-Escalation Trial
    Modlin, L. A.
    Choi, C. Y. H.
    Gibbs, I. C.
    Wakelee, H. A.
    Neal, J.
    Pinder-Schenck, M. C.
    Chang, S. D.
    Adler, J. R.
    Harsh, G. R.
    Soltys, S. G.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S178 - S178
  • [9] Phase I Dose Escalation Study of Thoracic Radiotherapy in Combination with Gefitinib in Patients with IIIB/IV Non-small Cell Lung Cancer
    Chen, J.
    Fan, M.
    Jiang, G.
    Fu, X.
    Xie, L.
    Xu, X.
    Zhang, G.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S110 - S111
  • [10] Accurate prediction of PTV and OAR doses for dose-escalation of non-small cell lung cancer patients
    Petit, S.
    Troost, E. G. C.
    Van Elmpt, W.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S127 - S128
12345